{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:42:13Z","timestamp":1771501333909,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41401-018-0153-0","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T08:28:11Z","timestamp":1537172891000},"page":"583-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice"],"prefix":"10.1038","volume":"40","author":[{"given":"Yang","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manyi","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"key":"153_CR1","unstructured":"The Annual Report of Drug Abuse Monitoring in China [China food and drug administration 2017 Aug 11]. http:\/\/www.sda.gov.cn\/WS01\/CL0844\/175994.html ."},{"key":"153_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","volume":"74","author":"JS Potter","year":"2013","unstructured":"Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, et al. Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). J Stud Alcohol Drugs. 2013;74:605\u201313.","journal-title":"J Stud Alcohol Drugs"},{"key":"153_CR3","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","volume":"174","author":"DA Fiellin","year":"2014","unstructured":"Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O'Connor PG, et al. Primary care-based buprenorphine taper vs. maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174:1947\u201354.","journal-title":"JAMA Intern Med"},{"key":"153_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/10550887.2015.1059225","volume":"34","author":"DM Novick","year":"2015","unstructured":"Novick DM, Salsitz EA, Joseph H, Kreek MJ. Methadone medical maintenance: an early 21st-century perspective. J Addict Dis. 2015;34:226\u201337.","journal-title":"J Addict Dis"},{"key":"153_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97\u2013129.","journal-title":"Neuropsychopharmacology"},{"key":"153_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev.psych.54.101601.145237","volume":"54","author":"TE Robinson","year":"2003","unstructured":"Robinson TE, Berridge KC. Addiction. Annu Rev Psychol. 2003;54:25\u201353.","journal-title":"Annu Rev Psychol"},{"key":"153_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0149-7634(97)00020-1","volume":"22","author":"TE Robinson","year":"1998","unstructured":"Robinson TE, Browman KE, Crombag HS, Badiani A. Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehav Rev. 1998;22:347\u201354.","journal-title":"Neurosci Biobehav Rev"},{"key":"153_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/35094560","volume":"2","author":"SE Hyman","year":"2001","unstructured":"Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001;2:695\u2013703.","journal-title":"Nat Rev Neurosci"},{"key":"153_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/sj.npp.1301564","volume":"33","author":"PW Kalivas","year":"2008","unstructured":"Kalivas PW, O\u2019Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology. 2008;33:166\u201380.","journal-title":"Neuropsychopharmacology"},{"key":"153_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.neuron.2011.01.017","volume":"69","author":"C Luscher","year":"2011","unstructured":"Luscher C, Malenka RC. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron. 2011;69:650\u201363.","journal-title":"Neuron"},{"key":"153_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","volume":"564","author":"ML Bouthenet","year":"1991","unstructured":"Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 1991;564:203\u201319.","journal-title":"Brain Res"},{"key":"153_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","volume":"20","author":"EV Gurevich","year":"1999","unstructured":"Gurevich EV, Joyce JN. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology. 1999;20:60\u201380.","journal-title":"Neuropsychopharmacology"},{"key":"153_CR13","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1038\/npp.2014.158","volume":"39","author":"MA Khaled","year":"2014","unstructured":"Khaled MA, Pushparaj A, Di Ciano P, Diaz J, Le Foll B. Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine seeking. Neuropsychopharmacology. 2014;39:3049\u201358.","journal-title":"Neuropsychopharmacology"},{"key":"153_CR14","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1046\/j.1460-9568.2002.02049.x","volume":"15","author":"B Foll Le","year":"2002","unstructured":"Le Foll B, Frances H, Diaz J, Schwartz JC, Sokoloff P. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci. 2002;15:2016\u201326.","journal-title":"Eur J Neurosci"},{"key":"153_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.euroneuro.2010.12.006","volume":"21","author":"J Liang","year":"2011","unstructured":"Liang J, Zheng X, Chen J, Li Y, Xing X, Bai Y, et al. Roles of BDNF, dopamine D(3) receptors, and their interactions in the expression of morphine-induced context-specific locomotor sensitization. Eur Neuropsychopharmacol. 2011;21:825\u201334.","journal-title":"Eur Neuropsychopharmacol"},{"key":"153_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00001756-200201210-00039","volume":"13","author":"H Aujla","year":"2002","unstructured":"Aujla H, Sokoloff P, Beninger RJ. A dopamine D3 receptor partial agonist blocks the expression of conditioned activity. Neuroreport. 2002;13:173\u20136.","journal-title":"Neuroreport"},{"key":"153_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neulet.2010.09.025","volume":"485","author":"T Li","year":"2010","unstructured":"Li T, Hou Y, Yan CX, Chen T, Zhao Y, Li SB. Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration. Neurosci Lett. 2010;485:256\u201360.","journal-title":"Neurosci Lett"},{"key":"153_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.09.007","volume":"126","author":"ZB You","year":"2017","unstructured":"You ZB, Gao JT, Bi GH, He Y, Boateng C, Cao J, et al. The novel dopamine D3 receptor antagonists\/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats. Neuropharmacology. 2017;126:190\u20139.","journal-title":"Neuropharmacology"},{"key":"153_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1369-1600.2011.00317.x","volume":"17","author":"R Song","year":"2012","unstructured":"Song R, Yang RF, Wu N, Su RB, Li J, Peng XQ, et al. YQA14: a novel dopamine D-3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D-3 receptor-knockout mice. Addict Biol. 2012;17:259\u2013273.","journal-title":"Addict Biol"},{"key":"153_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/bdd.1897","volume":"35","author":"F Liu","year":"2014","unstructured":"Liu F, Zhuang X, Yang C, Li Z, Xiong S, Zhang Z, et al. Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction. Biopharm Drug Dispos. 2014;35:296\u2013307.","journal-title":"Biopharm Drug Dispos"},{"key":"153_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1369-1600.2011.00317.x","volume":"17","author":"R Song","year":"2012","unstructured":"Song R, Yang RF, Wu N, Su RB, Li J, Peng XQ, et al. YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice. Addict Biol. 2012;17:259\u201373.","journal-title":"Addict Biol"},{"key":"153_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2013.04.042","volume":"72","author":"R Song","year":"2013","unstructured":"Song R, Zhang HY, Peng XQ, Su RB, Yang RF, Li J, et al. Dopamine D3 receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice. Neuropharmacology. 2013;72:82\u20137.","journal-title":"Neuropharmacology"},{"key":"153_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ejphar.2013.10.026","volume":"720","author":"R Hu","year":"2013","unstructured":"Hu R, Song R, Yang R, Su R, Li J. The dopamine D(3) receptor antagonist YQA14 that inhibits the expression and drug-prime reactivation of morphine-induced conditioned place preference in rats. Eur J Pharmacol. 2013;720:212\u20137.","journal-title":"Eur J Pharmacol"},{"key":"153_CR24","doi-asserted-by":"publisher","first-page":"17675","DOI":"10.1073\/pnas.1205297109","volume":"109","author":"R Song","year":"2012","unstructured":"Song R, Zhang HY, Li X, Bi GH, Gardner EL, Xi ZX. Increased vulnerability to cocaine in mice lacking dopamine D3 receptors. Proc Natl Acad Sci U S A. 2012;109:17675\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"153_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/aps.2015.96","volume":"37","author":"L Sun","year":"2016","unstructured":"Sun L, Song R, Chen Y, Yang RF, Wu N, Su RB, et al. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice. Acta Pharmacol Sin. 2016;37:157\u201365.","journal-title":"Acta Pharmacol Sin"},{"key":"153_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neuropharm.2013.10.010","volume":"77","author":"R Song","year":"2014","unstructured":"Song R, Bi GH, Zhang HY, Yang RF, Gardner EL, Li J, et al. Blockade of D3 receptors by YQA14 inhibits cocaine\u2019s rewarding effects and relapse to drug-seeking behavior in rats. Neuropharmacology. 2014;77:398\u2013405.","journal-title":"Neuropharmacology"},{"key":"153_CR27","doi-asserted-by":"publisher","first-page":"9595","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002","volume":"22","author":"SR Vorel","year":"2002","unstructured":"Vorel SR, Ashby CR Jr, Paul M, Liu X, Hayes R, Hagan JJ, et al. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci. 2002;22:9595\u20139603.","journal-title":"J Neurosci"},{"key":"153_CR28","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/sj.npp.1300912","volume":"31","author":"ZX Xi","year":"2006","unstructured":"Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR Jr, et al. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine\u2019s rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology. 2006;31:1393\u20131405.","journal-title":"Neuropsychopharmacology"},{"key":"153_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","volume":"396","author":"TE Robinson","year":"1986","unstructured":"Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986;396:157\u201398.","journal-title":"Brain Res"},{"key":"153_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0091-3057(74)90060-4","volume":"2","author":"DS Segal","year":"1974","unstructured":"Segal DS, Mandell AJ. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav. 1974;2:249\u201355.","journal-title":"Pharmacol Biochem Behav"},{"key":"153_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1124\/pr.109.001933","volume":"63","author":"JD Steketee","year":"2011","unstructured":"Steketee JD, Kalivas PW. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev. 2011;63:348\u201365.","journal-title":"Pharmacol Rev"},{"key":"153_CR32","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1037\/0735-7044.110.6.1397","volume":"110","author":"SG Anagnostaras","year":"1996","unstructured":"Anagnostaras SG, Robinson TE. Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci. 1996;110:1397\u20131414.","journal-title":"Behav Neurosci"},{"key":"153_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","volume":"25","author":"RC Pierce","year":"1997","unstructured":"Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997;25:192\u2013216.","journal-title":"Brain Res Brain Res Rev"},{"key":"153_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/cns.12276","volume":"20","author":"XS Liu","year":"2014","unstructured":"Liu XS, Hou Y, Yan TL, Guo YY, Han W, Guan FL, et al. Dopamine D3 receptor-regulated NR2B subunits of N-methyl-d-aspartate receptors in the nucleus accumbens involves in morphine-induced locomotor activity. CNS Neurosci Ther. 2014;20:823\u20139.","journal-title":"Cns Neurosci Ther"},{"key":"153_CR35","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1021\/acs.jmedchem.5b00776","volume":"58","author":"CA Boateng","year":"2015","unstructured":"Boateng CA, Bakare OM, Zhan J, Banala AK, Burzynski C, Pommier E, et al. High affinity dopamine D3 receptor (D3R)-selective antagonists attenuate heroin self-administration in wild-type but not D3R knockout mice. J Med Chem. 2015;58:6195\u20136213.","journal-title":"J Med Chem"},{"key":"153_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","volume":"18","author":"TE Robinson","year":"1993","unstructured":"Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18:247\u2013291.","journal-title":"Brain Res Brain Res Rev"},{"key":"153_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1152\/physrev.1991.71.1.155","volume":"71","author":"M Moal Le","year":"1991","unstructured":"Le Moal M, Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev. 1991;71:155\u2013234.","journal-title":"Physiol Rev"},{"key":"153_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/syn.890050104","volume":"5","author":"PW Kalivas","year":"1990","unstructured":"Kalivas PW, Duffy P. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 1990;5:48\u201358.","journal-title":"Synapse"},{"key":"153_CR39","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","volume":"89","author":"R Spanagel","year":"1992","unstructured":"Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A. 1992;89:2046\u20132050.","journal-title":"Proc Natl Acad Sci USA"},{"key":"153_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992;12:483\u2013488.","journal-title":"J Neurosci"},{"key":"153_CR41","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1523\/JNEUROSCI.12-07-02623.1992","volume":"12","author":"MA Klitenick","year":"1992","unstructured":"Klitenick MA, DeWitte P, Kalivas PW. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 1992;12:2623\u20132632.","journal-title":"J Neurosci"},{"key":"153_CR42","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(25)39324-9","volume":"266","author":"DP Devine","year":"1993","unstructured":"Devine DP, Leone P, Pocock D, Wise RA. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther. 1993;266:1236\u20131246.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0153-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0153-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0153-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:34:32Z","timestamp":1751898872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0153-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0153-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}